Dr. Marks on PHENIX Trial Data in HER2+ Breast Cancer - OncLive

Dr. Marks on PHENIX Trial Data in HER2+ Breast Cancer  OncLiveDouglas K. Marks, MD, discusses data from a small subset of patients with HER2-positive breast cancer enrolled in the PHENIX trial, which was presented at the ...